| Company Name: |
BOC Sciences |
| Tel: |
1-631-485-4226; 16314854226 |
| Email: |
info@bocsci.com |
| Company Name: |
Sigma-Aldrich |
| Tel: |
021-61415566 800-8193336 |
| Email: |
orderCN@merckgroup.com |
4-(azetidin-1-yl)-7-methyl-5-{1-methyl-5-[5-(trifluoromethyl)pyridin-2-yl]-1H-pyrazol-4-yl}imidazo[5,1-f][1,2,4]triazine manufacturers
- PF-05180999
-
- $40.00
-
2026-07-14
- CAS:1394033-54-5
- Purity: 99.82%
- Supply Ability: 10g
|
| | 4-(azetidin-1-yl)-7-methyl-5-{1-methyl-5-[5-(trifluoromethyl)pyridin-2-yl]-1H-pyrazol-4-yl}imidazo[5,1-f][1,2,4]triazine Basic information |
| Product Name: | 4-(azetidin-1-yl)-7-methyl-5-{1-methyl-5-[5-(trifluoromethyl)pyridin-2-yl]-1H-pyrazol-4-yl}imidazo[5,1-f][1,2,4]triazine | | Synonyms: | PF 5180999;4-(azetidin-1-yl)-7-methyl-5-{1-methyl-5-[5-(trifluoromethyl)pyridin-2-yl]-1H-pyrazol-4-yl}imidazo[5,1-f][1,2,4]triazine;4-(1-Azetidinyl)-7-methyl-5-[1-methyl-5-[5-(trifluoromethyl)-2-pyridinyl]-1H-pyrazol-4-yl]-imidazo[5,1-f][1,2,4]triazine;Imidazo[5,1-f][1,2,4]triazine, 4-(1-azetidinyl)-7-methyl-5-[1-methyl-5-[5-(trifluoromethyl)-2-pyridinyl]-1H-pyrazol-4-yl]-;PF-05180999 >=98% (HPLC);PF 05180999,PF05180999 | | CAS: | 1394033-54-5 | | MF: | C19H17F3N8 | | MW: | 414.39 | | EINECS: | | | Product Categories: | | | Mol File: | 1394033-54-5.mol | ![4-(azetidin-1-yl)-7-methyl-5-{1-methyl-5-[5-(trifluoromethyl)pyridin-2-yl]-1H-pyrazol-4-yl}imidazo[5,1-f][1,2,4]triazine Structure](CAS/20180808/GIF/1394033-54-5.gif) |
| | 4-(azetidin-1-yl)-7-methyl-5-{1-methyl-5-[5-(trifluoromethyl)pyridin-2-yl]-1H-pyrazol-4-yl}imidazo[5,1-f][1,2,4]triazine Chemical Properties |
| density | 1.57±0.1 g/cm3(Predicted) | | storage temp. | room temp | | solubility | DMSO: 10 mM | | form | powder | | pka | 3.88±0.30(Predicted) | | color | white to beige |
| RIDADR | UN 2811 6.1 / PGIII | | WGK Germany | WGK 3 | | Storage Class | 6.1C - Combustible acute toxic Cat.3 toxic compounds or compounds which causing chronic effects | | Hazard Classifications | Acute Tox. 3 Oral Eye Irrit. 2 Skin Irrit. 2 STOT SE 3 |
| | 4-(azetidin-1-yl)-7-methyl-5-{1-methyl-5-[5-(trifluoromethyl)pyridin-2-yl]-1H-pyrazol-4-yl}imidazo[5,1-f][1,2,4]triazine Usage And Synthesis |
| Uses | PF 05180999 (cas# 1394033-54-5) is a useful research chemical. Potent PDE2A inhibitor | | Biochem/physiol Actions | PF-05180999 is an inhibitor of cyclic nucleotide phosphodiesterase-2 (PDE2). | | in vivo | PF-05180999 (Compound 30; 0.032-0.32 mg/kg mg/kg, s.c.) dramatically reduces the working memory errors produced by ketamine in a working memory radial arm maze (RAM) model in rats. PF-05180999 causes acute and exposure-dependent elevation in the accumulation of cGMP bulk levels in the cortex, striatum, and hippocampus, but with no changes in cAMP and the associated downstream phospho-cAMP response element-binding protein (p-CREB) in mice[1]. | | IC 50 | PDE2A: 1.6 nM (IC50); PDE10A1: 2.03 μM (IC50); PDE11A4: 26.969 μM (IC50); PDE7B: 50.09 μM (IC50) | | storage | Store at -20°C |
| | 4-(azetidin-1-yl)-7-methyl-5-{1-methyl-5-[5-(trifluoromethyl)pyridin-2-yl]-1H-pyrazol-4-yl}imidazo[5,1-f][1,2,4]triazine Preparation Products And Raw materials |
|